RT @atlasventure: We are proud to announce the closing of Atlas Venture Fund XIV today, our newest early-stage fund to enable the creation…

RT @LifeSciVC: Mariana Oncology’s Radiopharm Platform Acquired By Novartis It's always about people. This M&A reinforces the axiom in vent…

RT @beyazlab: I ask for your help to support this Turkey Earthquake Fund that will directly help affected families…

RT @LifeSciVC: Here’s the Atlas Venture 2022 Year In Review. This year, given the 2+ year rollercoaster in the mkts, we start with a deep…

RT @atlasventure: #Science2Startup is an opportunity for #lifescience researchers to showcase their startup ideas and network with top #bio…

RT @LifeSciVC: Atlas Venture 2021 Year In Review Here's our "state of the industry" talk (that we just shared with our LP's at our Annual M…

RT @atlasventure: We are proud to announce Atlas Venture Opportunity Fund II, a $300M fund dedicated to supporting our breakthrough portfol…

RT @atlasventure: Congratulations Versanis Bio, announcing $70M in Series A financing to advance bimagrumab into an advanced Phase 2 progra…

RT @endpts: “B cells have been such an attractive cell type,” said Aleks Radovic-Moreno, who co-founded Be Biopharma. “It just wasn’t their…

RT @atlasventure: Calling all academic researchers with innovative therapeutic startup ideas! Submit your proposal to #Science2Startup to…

@ElstarTx @loewan I really hope that’s not actually Andreas’ secret twitter handle... way too much on his plate these days to be living a double life this whole time too!

@nickhaining @DanaFarber Remember when the lab was small enough that we had lab meetings in that office?? Good memories there...

@nickhaining You have left me with the same curse and I can’t get away from it!! @SENGLAITAN @ElstarTx @caincw @ablT315I - perhaps this explains a thing or two on my PPT OCD-ness..

RT @nickhaining: So, a spot of news: delighted to say I’ll be starting as VP, Oncology @Merck in Jan. Very sad to leave phenomenal colleagu…

RT @akerotx: Akero Therapeutics today announces that Andrew Cheng, MD, PhD, former CMO of Gilead Sciences, has joined as President and CEO…

@ElstarTx @MonstahTruck This is what you guys do when I am not there?! :D

RT @mderkacz: FDA has assigned a December 26 goal date for our Fast Track and Priority Review NDA for CAM2038 Weekly & Monthly injectable.…

RT @akerotx: Today marks the launch of @AkeroTx working to transform the treatment of non-alcoholic steatohepatitis, or NASH, and other ser…

RT @Dr_Tobi_OG: Sometimes, its good to have Skin in the Game. I wanted to share our latest article on reimbursements for all doctors, espec…

RT @Dr_Tobi_OG: so excited to have had the opportunity to write about easy ways to make improve dermatology practice -